Received Feb 18, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMVB043A | — |
We mixed it with sterile solution instead of the compound; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 36-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVB043A, expiry date 31-JUL-2025) for prophylaxis. On 28-JAN-2025, the patient received Menveo. On 28-JAN-2025, an unknown time after receiving Menveo, the patient experienced wrong solution used in drug reconstitution (Verbatim: We mixed it with sterile solution instead of the compound). The outcome of the wrong solution used in drug reconstitution was unknown. Additional Information: GSK Receipt Date: 28-JAN-2025 The nurse reported the following for Menveo 2-vial presentation, mixed it with sterile solution instead of the Compound, which led wrong solution used in drug reconstitution. The reporter consented to follow up.